Responses
Other responses
Jump to comment:
- Published on: 9 January 2022
- Published on: 9 January 2022
- Published on: 9 January 2022Re: Implementation of NICE guidance on the use of implantable cardioverter defibrillatorsDear Editor,Show More
We thank Drs Plummer and McComb for their interest in our estimate of the implications of the recently published NICE guidelines for United Kingdom electrophysiology centres [1]. We agree that an assessment of the workload implications of these guidelines is important for resource planning.
Using data gathered in clinical trials designed for different ends will always require assumptions and can therefor...
Conflict of Interest:
None declared. - Published on: 9 January 2022Implementation of NICE guidance on the use of implantable cardioverter defibrillatorsShow More
Dear Editor,
The activity monitoring analysis of the UK-HEART study published by Gall et al. [1] is very welcome. They calculate that screening of 551 ambulant patients with stable heart failure according to NICE guidance [2] would result in 142 electrophysiology studies (EPS) and the implantation of 50 implantable cardioverter defibrillators (ICDs). Thus 9% of their population were found to have a primary preve...
Conflict of Interest:
None declared.